Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: CETROTIDE
Active substances:
Estonian, English, Latin
ATC code: H01CC02
Dosage form: powder and solvent for solution for injection
Strength: 0,25mg
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Indication: Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques. In clinical trials Cetrotide was used with human menopausal gonadotropin (HMG), however, limited experience with recombinant follicule-stimulating hormone (FSH) suggested similar efficacy.
Safety features: Yes
Marketing authorization holder: Merck Europe B.V. 
Marketing authorization number: EU/1/99/100 
Marketing authorization issued on: August 27, 1999 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1043356  CETROTIDE  powder and solvent for solution for injection  0,25mg 1TK  Prescription  100% 50%    18.06.2024    lahusti süstlis 1 ml 
1064696  CETROTIDE  powder and solvent for solution for injection  0,25mg 7TK  Prescription          lahusti süstlis 1 ml 
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere